Home Applications 215320 Application 215320
Type NDA
Sponsor HIKMA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 COMBOGESIC IV ACETAMINOPHEN; IBUPROFEN SODIUM SOLUTION;INTRAVENOUS 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N215320-001 COMBOGESIC IV ACETAMINOPHEN; IBUPROFEN SODIUM 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17
Orange Book patents# Current patent rows page 1 of 1 · 10 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N215320-001 11446266 2031-10-26 U-3744 2023-11-16 N215320-001 11446266 2031-10-26 U-3745 2023-11-16 N215320-001 11896567 2031-10-26 U-3744 2024-03-12 N215320-001 11896567 2031-10-26 U-3745 2024-03-12 N215320-001 12220392 2031-10-26 U-4306 2025-11-06 N215320-001 12220392 2031-10-26 U-4307 2025-11-06 N215320-001 11389416 2035-07-17 Drug product 2023-11-16 N215320-001 12083087 2035-07-17 U-3744 2024-10-08 N215320-001 12083087 2035-07-17 U-3745 2024-10-08 N215320-001 11213498 2036-01-14 Drug product 2023-11-16
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N215320-001 NP 2026-10-17
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 a72a2bbeb626…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215320-001 COMBOGESIC IV 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-17 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 4 · 128 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N215320-001 11446266 2031-10-26 U-3744 2023-11-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215320-001 11446266 2031-10-26 U-3745 2023-11-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215320-001 11896567 2031-10-26 U-3744 2024-03-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215320-001 11896567 2031-10-26 U-3745 2024-03-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215320-001 12220392 2031-10-26 U-4306 2025-11-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215320-001 12220392 2031-10-26 U-4307 2025-11-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215320-001 11389416 2035-07-17 Drug product 2023-11-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215320-001 12083087 2035-07-17 U-3744 2024-10-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215320-001 12083087 2035-07-17 U-3745 2024-10-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215320-001 11213498 2036-01-14 Drug product 2023-11-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215320-001 11446266 2031-10-26 U-3744 2023-11-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215320-001 11446266 2031-10-26 U-3745 2023-11-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215320-001 11896567 2031-10-26 U-3744 2024-03-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215320-001 11896567 2031-10-26 U-3745 2024-03-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215320-001 12220392 2031-10-26 U-4306 2025-11-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215320-001 12220392 2031-10-26 U-4307 2025-11-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215320-001 11389416 2035-07-17 Drug product 2023-11-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215320-001 12083087 2035-07-17 U-3744 2024-10-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215320-001 12083087 2035-07-17 U-3745 2024-10-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215320-001 11213498 2036-01-14 Drug product 2023-11-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215320-001 11446266 2031-10-26 U-3744 2023-11-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215320-001 11446266 2031-10-26 U-3745 2023-11-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215320-001 11896567 2031-10-26 U-3744 2024-03-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215320-001 11896567 2031-10-26 U-3745 2024-03-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215320-001 11389416 2035-07-17 Drug product 2023-11-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215320-001 12083087 2035-07-17 U-3744 2024-10-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215320-001 12083087 2035-07-17 U-3745 2024-10-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215320-001 11213498 2036-01-14 Drug product 2023-11-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215320-001 11446266 2031-10-26 U-3744 2023-11-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215320-001 11446266 2031-10-26 U-3745 2023-11-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215320-001 11896567 2031-10-26 U-3744 2024-03-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215320-001 11896567 2031-10-26 U-3745 2024-03-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215320-001 11389416 2035-07-17 Drug product 2023-11-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215320-001 12083087 2035-07-17 U-3744 2024-10-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215320-001 12083087 2035-07-17 U-3745 2024-10-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215320-001 11213498 2036-01-14 Drug product 2023-11-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215320-001 11446266 2031-10-26 U-3744 2023-11-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215320-001 11446266 2031-10-26 U-3745 2023-11-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215320-001 11896567 2031-10-26 U-3744 2024-03-12 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215320-001 11896567 2031-10-26 U-3745 2024-03-12 b8a1b40f171c…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join COMBOGESIC IV ACETAMINOPHEN AND IBUPROFEN INJECTION Hikma Pharmaceuticals USA Inc. be408a5a-48e4-43c0-9cb1-bbf830b54f5b 2024-11-25 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 215320 application number: NDA215320
Documents# Document, Submission type, Date table Document Submission type Date 80359 SUPPL 2024-11-25 80349 SUPPL 2024-11-25 79703 ORIG 2024-09-23 75883 ORIG 2023-10-20 75838 ORIG 2023-10-18